Janus kinase inhibitors alter NK cell phenotypes and inhibit their antitumour capacity

Loïc Meudec1,2, Pauline Richebé2, Juliette Pascaud1

  • 1Center for Immunology of Viral Infections and Autoimmune Diseases, INSERM UMR 1184, Université Paris-Saclay, Le Kremlin Bicêtre, Paris, France.

Abstract

Insights

Janus kinase inhibitors (JAKi) impact natural killer (NK) cell function and antitumor activity. This study reveals that JAKi alter NK cell activation and cytotoxicity, raising questions about their role in cancer risk.

Area of Science:

  • Immunology
  • Pharmacology
  • Oncology

Background:

  • Janus kinase inhibitors (JAKi) are effective for rheumatoid arthritis (RA).
  • Concerns exist regarding cancer risk associated with JAKi use.
  • Natural killer (NK) cells play a crucial role in antitumor responses.

Purpose of the Study:

  • To investigate the impact of JAK inhibitors on NK cells in rheumatoid arthritis patients.
  • To assess the effects of specific JAK inhibitors (tofacitinib, baricitinib, upadacitinib, filgotinib) on NK cell phenotype and function.

Main Methods:

  • Ex vivo phenotyping of NK cells from RA patients treated with JAKi or methotrexate (MTX).
  • In vitro culture of NK cells from healthy donors with JAKi or DMSO.
  • Assessment of NK cell function including activation markers, cytokine production, and cytotoxicity against tumor cell lines.

Main Results:

  • JAKi treatment, particularly tofacitinib (TOFA) and upadacitinib (UPA), reduced NK cell activation markers (CD69, NKp30).
  • Tofacitinib impaired NK cell degranulation (CD107a) and cytokine production (IFN-γ/TNF) upon stimulation.
  • NK cells exposed to tofacitinib exhibited reduced cytotoxicity against A549 and SU-DHL-4 tumor cell lines.

Conclusions:

  • JAK inhibitors have a significant impact on NK cell phenotype and function.
  • These drugs impair NK cell antitumor activity, with varying effects among different JAKi.
  • The observed effects on NK cells warrant further investigation into their contribution to the increased tumor risk associated with JAKi, especially tofacitinib.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.6K